Skip to content
Docus logo — Docus AI is the first AI layer on top of any LIS, automating...

Docus

Docus AI is the first AI layer on top of any LIS, automating result interpretation, provider/patient engagement, and ops

Founded 2021 United States Wilmington, United States 23 employees Pre-Seed Total: $750.00K AI, B2B +3

General Information

Company Name Docus
Founded Year 2021
Location United States Wilmington, United States
Founders / Decision Makers
Team member
Employees 23
Industries AI, B2B, B2C +2
Funding Stage Pre-Seed
Business Model B2B, SaaS, B2C
Revenue Model Subscription, Usage Based, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with Docus. To contact Docus, visit docus.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Docus compare?

A PDF of Docus and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Docus soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Docus

Docus, founded in 2021, is positioned at the forefront of healthcare innovation, with a mission encapsulated in its slogan: "Docus aims to enhance human health by combining cutting-edge technologies and top medical expertise."

The company delivers an AI‑powered health platform designed to revolutionize patient care by seamlessly connecting patients, doctors, and labs. Operating within multiple key industries—AI, B2B, B2C, Health Care, and SaaS—Docus offers solutions that are as versatile as they are innovative, providing substantial value both in business-to-business and direct consumer engagements.

Headquartered in the United States, Docus recently secured a $250.00K Pre Seed Round investment on 20 February 2023 from Triple S Ventures, underscoring investor confidence in its growth potential. This funding is expected to fuel further development of its platform, enhance user experiences, and broaden its market reach.

Business keywords: AI-powered health platform, personalized health reports, medical expertise, health technology, healthcare AI, telemedicine

Services & Products

AI Interpretation of Test Results
Clinical Report Generation
Patient-Friendly Reports
AI Compliance Agent
Digital Requisitions System
Context-Aware AI Assistants

Target Customers

Diagnostic Labs Direct-to-Consumer Labs Reference Labs In-House Hospital Labs Doctors Patients

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $250.00K 1
Triple S Ventures
20 Feb 2023
Seed Round Undisclosed 1
BANA Angels
20 Sep 2022
Pre Seed Round $500.00K 2
BigStory VC, KING. LUICIEFFER
30 Jun 2022

Docus Alternatives & Competitors

View All Alternatives
Docus vs
Labplus
Labplus Poland

Transforming laboratory results into personalized health guidance for patients

Pre-Seed
39 employees
AI, Health Care
Docus vs

Redefining Healthcare: Swift, Accurate, and Always Accessible

Merged
18 employees
AI, Health Care
Docus vs
DeHealth
DeHealth United States

The 1st Health Super App to safely store, analyze, and manage health data 24/7 worldwide. BlockChain...

Grant
25 employees
AI, Blockchain

FAQ About Docus

Docus AI is the first AI layer on top of any LIS, automating result interpretation, provider/patient engagement, and ops
Docus was founded in 2021.
Docus is headquartered in Wilmington, United States.
Docus operates in AI, B2B, B2C, Health Care and SaaS. Its work centres on AI-powered health platform, personalized health reports, medical expertise and health technology. Its customers include Diagnostic Labs, Direct-to-Consumer Labs and Reference Labs.
Docus has a B2B, SaaS and B2C business model. Its revenue comes from Subscription, Usage Based and Tiered Pricing.
Docus has approximately 23 employees.
Docus has completed 3 funding rounds, raising a total of $750.00K. The latest funding stage is Pre-Seed.
Docus offers: AI Interpretation of Test Results, Clinical Report Generation, Patient-Friendly Reports, AI Compliance Agent, Digital Requisitions System, Context-Aware AI Assistants.
Top alternatives and competitors to Docus include Labplus, mfine, DeHealth, VoiceMed, ScriptChain Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Docus and Labplus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Docus, https://bouncewatch.com/company/docus, updated 23 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout